Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression

Human Gene Therapy Methods

Volumn 24, Issue 4, 2013, Pages 270-278

  Chen, Shu Jen ^a   Johnston, Julie ^a   Sandhu, Arbans ^a   Bish, Lawrence T ^b   Hovhannisyan, Ruben ^a   Jno Charles, Odella ^a   Lee Sweeney, H ^b   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE; RAPAMYCIN; TRANSCRIPTION FACTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; IN VIVO GENE TRANSFER; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SEROTYPE; TISSUE SPECIFICITY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; DEPENDOVIRUS; GENE EXPRESSION; GENES, REPORTER; GENETIC THERAPY; GENETIC VECTORS; LIVER; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; ORGAN SPECIFICITY; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 84882977506     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.129     Document Type: Article

References (37)

1. Allocca, M., Mussolino, C., Garcia-Hoyos, M., et al. (2007). Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors. J. Virol. 81, 11372-11380. (Pubitemid 47536108)
2. Auricchio, A., Rivera, V.M., Clackson, T., et al. (2002). Pharmacological regulation of protein expression from adeno-associated viral vectors in the eye. Mol. Ther. 6, 238-242. (Pubitemid 36336131)
3. Bish, L.T., Morine, K., Sleeper, M.M., et al. (2008). Adenoassociated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum. Gene Ther. 19, 1359-1368.
4. Cearley, C.N., Vandenberghe, L.H., Parente, M.K., et al. (2008). Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 16, 1710-1718.
5. Clackson, T. (1997). Controlling mammalian gene expression with small molecules. Curr. Opin. Chem. Biol. 1, 210-218. (Pubitemid 127437147)
6. Fang, J., Yi, S., Simmons, A., et al. (2007). An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo. Mol. Ther. 15, 1153-1159. (Pubitemid 46813618)
7. Foust, K.D., Nurre, E., Montgomery, C.L., et al. (2009). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59-65.
8. Fu, H., Dirosario, J., Killedar, S., et al. (2011). Correction of neurological disease of mucopolysaccharidosis IIIB in adult mice by rAAV9 trans-blood-brain barrier gene delivery. Mol. Ther. 19, 1025-1033.
9. Gao, G., Vandenberghe, L.H., Alvira, M.R., et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. (Pubitemid 38715936)
10. Geisler, A., Jungmann, A., Kurreck, J., et al. (2011). micro-RNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors. Gene Ther. 18, 199-209.
11. Inagaki, K., Fuess, S., Storm, T.A., et al. (2006). Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8. Mol. Ther. 14, 45-53. (Pubitemid 43899488)
12. Johnston, J., Tazelaar, J., Rivera, V.M., et al. (2003). Regulated expression of erythropoietin from an AAV vector safely improves the anemia of b-thalassemia in a mouse model. Mol. Ther. 7, 493-497. (Pubitemid 36553418)
13. Kim, S.R., Kareva, T., Yarygina, O., et al. (2012). AAV transduction of dopamine neurons with constitutively active Rheb protects from neurodegeneration and mediates axon regrowth. Mol. Ther. 20, 275-286.
14. Kornegay, J.N., Li, J., Bogan, J.R., et al. (2010). Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs. Mol. Ther. 18, 1501-1508.
15. Li, W., Asokan, A., Wu, Z., et al. (2008). Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles. Mol. Ther. 16, 1252-11260.
16. Limberis, M.P., and Wilson, J.M. (2006). Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc. Natl. Acad. Sci. U.S.A. 103, 12993-12998. (Pubitemid 44338905)
17. Lock, M., Alvira, M., Vandenberghe, L.H., et al. (2010). Rapid, simple, and versatile manufacturing of recombinant adenoassociated viral vectors at scale. Hum. Gene Ther. 21, 1259-1271.
18. Masamizu, Y., Okada, T., Kawasaki, K., et al. (2011). Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Neuroscience 193, 249-258.
19. Pacak, C.A., Sakai, Y., Thattaliyath, B.D., et al. (2008). Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice. Genet. Vaccines Ther. 6, 13.
20. Pleger, S.T., Shan, C., Ksienzyk, J., et al. (2011). Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci. Transl. Med. 3, 92ra64.
21. Pollock, R., and Clackson, T. (2002). Dimerizer-regulated gene expression. Curr. Opin. Biotechnol. 13, 459-467. (Pubitemid 35379932)
22. Prasad, K.M., Smith, R.S., Xu, Y., and French, B.A. (2011). A single direct injection into the left ventricular wall of an adenoassociated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction. J. Gene Med. 13, 333-341.
23. Pulicherla, N., Shen, S., Yadav, S., et al. (2011). Engineering liverdetargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol. Ther. 19, 1070-1078.
24. Qiao, C., Yuan, Z., Li, J., et al. (2011). Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver. Gene Ther. 18, 403-410.
25. Rivera, V.M., Ye, X., Courage, N.L., et al. (1999). Long-term regulated expression of growth hormone in mice after intramuscular gene transfer. Proc. Natl. Acad. Sci. U.S.A. 96, 8657-8662. (Pubitemid 29354847)
26. Rivera, V.M., Gao, G.P., Grant, R.L., et al. (2005). Long-term pharmacologically regulated expression of erythropoietin in primates following AAV-mediated gene transfer. Blood 105, 1424-1430. (Pubitemid 40223657)
27. Sanftner, L.M., Rivera, V.M., Suzuki, B.M., et al. (2006). Dimerizer regulation of AADC expression and behavioral response in AAV-transduced 6-OHDA lesioned rats. Mol. Ther. 13, 167-174. (Pubitemid 41763495)
28. Sarkar, R., Mucci, M., Addya, S., et al. (2006). Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia a dogs and mice. Hum. Gene Ther. 17, 427-439.
29. Snyder, B.R., Gray, S.J., Quach, E.T., et al. (2011). Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum. Gene Ther. 22, 1129-1135.
30. Sun, B., Li, S., Bird, A., and Koeberl, D.D. (2010). Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease. Gene Ther. 17, 1500-1505.
31. Szymczak, A.L., Workman, C.J., Wang, Y., et al. (2004). Correction of multi-gene deficiency in vivo using a single "selfcleaving" 2A peptide-based retroviral vector. Nat. Biotechnol. 22, 589-594. (Pubitemid 38585911)
32. Tarantal, A.F., and Lee, C.C. (2010). Long-term luciferase expression monitored by bioluminescence imaging after adeno-associated virus-mediated fetal gene delivery in rhesus monkeys (Macaca mulatta). Hum. Gene Ther. 21, 143-148.
33. Vanrell, L., Di Scala, M., Blanco, L., et al. (2011). Development of a liver-specific Tet-on inducible system for AAV vectors and its application in the treatment of liver cancer. Mol. Ther. 19, 1245-1253.
34. Wang, B., Li, J., Fu, F.H., et al. (2008). Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther. 15, 1489-1499.
35. Wang, J., Voutetakis, A., Papa, M., et al. (2006). Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands. Gene Ther. 13, 187-190. (Pubitemid 43039910)
36. Wang, L., Calcedo, R., Wang, H., et al. (2010). The pleiotropic effects of natural AAV infections on liver-directed gene transfer in macaques. Mol. Ther. 18, 126-134.
37. Zincarelli, C., Soltys, S., Rengo, G., and Rabinowitz, J.E. (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073-1080. (Pubitemid 351737072)